Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era
International Journal of Molecular Sciences · 28.02.2026 · 27 (5) · 2307
DOI: 10.3390/ijms27052307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2026. Verfasst von Nirmal Pandit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathology, Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia 2408, Cyprus. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neuroendocrine Tumors, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pituitary neuroendocrine tumors (PitNETs) constitute a significant proportion of primary intracranial neoplasms and were historically differentiated based on clinical hormone excess syndromes and tinctorial properties. The 5th edition of the WHO classification introduces a paradigm shift towards the lineage-based taxonomy based on the cell-specific expression of transcription factors (TFs). This overview focuses on the biological justifications and diagnostic value of the core TFs of Pituitary-Specific Positive Transcription Factor 1 (PIT1), T-Box Pituitary Transcription Factor (TPIT), and Steroidogenic Factor 1 (SF1), which signify the somatotroph, lactotroph, thyrotroph, corticotroph, and gonadotroph lineages, respectively. By focusing on TF expressions instead of hormone immunoreactivity, pathologists can better subtype clinically non-functioning tumors, effectively relegating the previously overutilized null cell category to about 1% of cases. The TF-based classification is also essential in discriminating high-risk histotypes of silent corticotroph tumors, sparsely granulated somatotrophs, and immature PIT1-lineage PitNETs, which are linked to a higher invasiveness and recurrence. We suggest a practical, stepwise immunohistochemical diagnostic algorithm with the integration of ancillary markers (e.g., GATA3 and ERα) to refine lineage assignment. New molecular correlates such as GNAS and USP8 mutations also add to this framework and guide the use of individualized treatment involving somatostatin analogs or dopamine agonists. And lastly, we discuss the ongoing issues of diagnosis of triple-negative and multilineage tumors and the growing importance of DNA methylation profiling and artificial intelligence in standardized reporting and improving precision management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathology, Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia 2408, Cyprus.
- Centre of Neuroscience and Integrative Brain Research (CENIBRE), University of Nicosia Medical School, Nicosia 2408, Cyprus.
ORCID-Profile: Nirmal Pandit, Yahya Wehbeh, Omar Itani, Dimitrios Kanakis
Zitieren
APA
Pandit, N., Wehbeh, Y., Itani, O., & Kanakis, D. (2026). Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era. International Journal of Molecular Sciences, 27(5), 2307. https://doi.org/10.3390/ijms27052307
Vancouver
Pandit N, Wehbeh Y, Itani O, Kanakis D. Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era. International Journal of Molecular Sciences. 2026;27(5):2307. doi:10.3390/ijms27052307
BibTeX
@article{Pandit2026,
author = {Pandit, Nirmal and Wehbeh, Yahya and Itani, Omar and Kanakis, Dimitrios},
title = {Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2307},
doi = {10.3390/ijms27052307}
}
EUVIMED